Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
Partner Content Partner Content Pain Therapeutics: Interviews AstraZeneca, Ensysce Bioscienc... Pain Therapeutics Exclusive Speaker Interviews Released
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face